PET imaging of macrophage mannose receptor–expressing macrophages in tumor stroma using 18F-radiolabeled camelid single-domain antibody fragments

A Blykers, S Schoonooghe, C Xavier… - Journal of Nuclear …, 2015 - Soc Nuclear Med
Tumor-associated macrophages constitute a major component of the stroma of solid tumors,
encompassing distinct subpopulations with different characteristics and functions. We …

18F-nanobody for PET imaging of HER2 overexpressing tumors

C Xavier, A Blykers, I Vaneycken, M D'Huyvetter… - Nuclear medicine and …, 2016 - Elsevier
Introduction Radiolabeled nanobodies are exciting new probes for molecular imaging due to
high affinity, high specificity and fast washout from the blood. Here we present the labeling …

Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques

G Bala, A Blykers, C Xavier, B Descamps… - European Heart …, 2016 - academic.oup.com
Aims Positron emission tomography–computed tomography (PET-CT) is a highly sensitive
clinical molecular imaging modality to study atherosclerotic plaque biology. Therefore, we …

[HTML][HTML] Clinical Translation of [68Ga]Ga-NOTA-anti-MMR-sdAb for PET/CT Imaging of Protumorigenic Macrophages

C Xavier, A Blykers, D Laoui, E Bolli, I Vaneyken… - Molecular imaging and …, 2019 - Springer
Purpose Macrophage mannose receptor (MMR, CD206) expressing tumor-associated
macrophages (TAM) are protumorigenic and was reported to negatively impact therapy …

Radiometal-labeled anti-VCAM-1 nanobodies as molecular tracers for atherosclerosis–impact of radiochemistry on pharmacokinetics

G Bala, M Crauwels, A Blykers, I Remory… - Biological …, 2019 - degruyter.com
Radiolabeling of nanobodies with radiometals by chelation has the advantage of being
simple, fast and easy to implement in clinical routine. In this study, we validated 68 Ga/ 111 In-…

PET imaging of MMR-expressing macrophages in tumor stroma using 18F-radiolabeled camelid single-domain antibody fragments.

A Blykers, S Schoonooghe, C Xavier… - Journal of Nuclear …, 2015 - Soc Nuclear Med
… These authors contributed equally Correspondence should be directed to Anneleen
Blykers: In … Tel: +32 2 477 4991; fax: +32 2 477 5017 E-mail address: anneleen.blykers@gmail.com …

Fully automated synthesis of 18F-FET using the Synthera Platform

I Vaneycken, A Blykers, C Xavier, V Caveliers - 2012 - Soc Nuclear Med
1476 Objectives The most widely used radiopharmaceutical in oncology, 18F-FDG, is
relatively suboptimal for detecting tumors in the brain due to the glycolytic metabolism in the …

Anti-HER2 Nanobodies: novel theranostic tools

C Xavier, M D'Huyvetter, A Blykers… - 7th annual meeting …, 2014 - researchportal.vub.be
Abstract Body: Introduction: Single domain camelid antibody fragments, nanobodies (nb) have
proven to be powerful probes tools for molecular imaging and are being tested in targeted …

[PDF][PDF] Molecular imaging of inflamed atherosclerotic plaque with 18F-anti-VCAM-1 nanobody and PET/CT

G Bala, A Blykers, C Xavier, K Gillis… - Euro-Echo Imaging …, 2014 - biblio.ugent.be
Purpose: Cardiac tests for diagnosing myocarditis lack sensitivity or specificity. We hypothesized
that contrast enhanced ultrasound molecular imaging (CEUMI) could detect endothelial …

Optimisation of the automated synthesis of 18F-FMISO using the Synthera® Platform

A Blykers - Journal of Labelled Compounds and …, 2011 - researchportal.vub.be
Objectives Demonstrating tumor hypoxia in vivo in a non-invasive manner by 18F-FMISO-PET
can be used to predict resistance to radiotherapy. The automated synthesis of 18F-FMISO …